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Modulation of defensive reactivity by GLRB allelic variation:
converging evidence from an intermediate phenotype approach
U Lueken1,10, M Kuhn2,10, Y Yang3, B Straube3, T Kircher3, H-U Wittchen4, B Pﬂeiderer5, V Arolt6, A Wittmann7, A Ströhle7, H Weber1,8,
A Reif8, K Domschke1,9, J Deckert1 and TB Lonsdorf2
Representing a phylogenetically old and very basic mechanism of inhibitory neurotransmission, glycine receptors have been
implicated in the modulation of behavioral components underlying defensive responding toward threat. As one of the ﬁrst ﬁndings
being conﬁrmed by genome-wide association studies for the phenotype of panic disorder and agoraphobia, allelic variation
in a gene coding for the glycine receptor beta subunit (GLRB) has recently been associated with increased neural fear network
activation and enhanced acoustic startle reﬂexes. On the basis of two independent healthy control samples, we here aimed to
further explore the functional signiﬁcance of the GLRB genotype (rs7688285) by employing an intermediate phenotype approach.
We focused on the phenotype of defensive system reactivity across the levels of brain function, structure, and physiology.
Converging evidence across both samples was found for increased neurofunctional activation in the (anterior) insular cortex in
GLRB risk allele carriers and altered fear conditioning as a function of genotype. The robustness of GLRB effects is demonstrated by
consistent ﬁndings across different experimental fear conditioning paradigms and recording sites. Altogether, ﬁndings provide
translational evidence for glycine neurotransmission as a modulator of the brain’s evolutionary old dynamic defensive system and
provide further support for a strong, biologically plausible candidate intermediate phenotype of defensive reactivity. As such,
glycine-dependent neurotransmission may open up new avenues for mechanistic research on the etiopathogenesis of fear and
anxiety disorders.
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INTRODUCTION
Glycine receptors, including its beta receptor subunit (GLRB), play
a major role for inhibitory neurotransmission. Recently, a genome-
wide association of GLRB with categorical (panic disorder (PD)) and
dimensional (agoraphobia (AG)) forms of fear and anxiety has
been reported,1 in particular for rs7688285 which was associated
with GLRB expression changes in post mortem tissue and reporter
gene assays. Increased neural fear network activation during fear
conditioning and increased acoustic startle reﬂexes were observed
in risk allele carriers, thus qualifying as a potential intermediate
phenotype of defensive system reactivity across different levels of
analyses, corresponding to the Research Domain Criteria (RDoC)
approach.2
In light of the recent ‘replication crisis’ in psychology and
neuroscience,3,4 such promising ﬁndings need to be followed up.
Direct replication attempts (for example, replication of genome-
wide association studies (GWAS) ﬁndings in an independent
sample as performed in the initial report) provide information
about the reproducibility of a speciﬁc phenomenon, but not
necessarily about the theoretical construct.3 Hence, direct
replications need to form a synergy with conceptual replications
targeting the same construct with divergent methodological
approaches and paradigms.3 Here we focus on ‘defensive
reactivity’ on a neurobiological level of analysis aiming to con-
ceptually replicate the previous report1 on fear conditioning and
startle responding.
Defensive behaviors are part of an evolutionary conserved
dynamic defense cascade that depends upon the proximity of
threat, as described in the predator imminence model.5,6 The
defensive system encompasses phylogenetically older adaptive
behaviors (startle reﬂex; ﬁght, ﬂight, freeze responses) to higher-
level integrated cognitive-affective coping systems.7 The under-
lying neural circuit is represented by the interplay of diverse
cortical structures such as the medial prefrontal cortex, anterior
cingulate cortex (ACC), insular cortex, hippocampus, and amyg-
dala that dynamically interact with midbrain structures (periaque-
ductal grey) mediating hard-wired defensive reﬂexes under
proximal threat.5,8–10
Phylogenetically old defensive responses are modulated by
individual learning experiences. Fear conditioning enables the
organism to avoid future threats in that important information
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(conditioned stimuli (CS)) signaling a potential threat (uncondi-
tioned stimulus (US)) elicits defensive reactions (conditioned fear
response). Fear conditioning is considered to be involved in the
pathogenesis of pathological anxiety and serves as experimental
model for the development of anxiety disorders. On a neural
level, fear conditioning involves multiple areas associated with
defensive responding such as the (pre-) motor cortex, medial
prefrontal cortex/ACC, anterior insula, amygdala, hippocampus
and thalamus.11,12
Human13,14 and animal studies15 evidence that genetic factors
represent a signiﬁcant source of individual variation in (aversive)
emotional-associative learning. At least one third of the variance in
human fear conditioning14 and the risk to develop anxiety
disorders16 has been attributed to genetic factors. The overall
startle magnitude in humans has been shown to be heritable (for
example, 59–61% in17 or 37–52% in18). Studies on the heritability
of task-related brain activity suggest moderate heritability of brain
activation in general19,20 and amygdala activation (to faces)
appears to be a temporally stable and trait-like measure.21 This
evidence presents fear conditioning and affective startle para-
digms as prime laboratory models for investigating genetic
inﬂuences on neurobiological mechanisms contributing to defen-
sive responding, fear and anxiety.
On the basis of previous ﬁndings1 and focusing on rs7688285
which phenotypically showed the most robust impact, we aimed
to conduct a conceptual replication by studying defensive
reactivity on the level of brain function, structure, and physiology.
We expected GLRB risk allele carriers to (a) exhibit increased fear
network activation during two different fear conditioning tasks in
regions related to the defensive system’s neuro-architecture such
as the brainstem, thalamus, amygdala, hippocampus, insula,
medial prefrontal cortex/ACC, and (pre-) motor cortex with
different effects for the early vs late acquisition (see1), (b) show
brain morphometric alterations in these areas of interest that
could underlie observed functional changes, and (c) show
impaired startle habituation as a subsequent behavioral outﬂow
of enhanced defensive system reactivity.
MATERIALS AND METHODS
Sample characteristics
Sample 1: Sample 1 from Hamburg was recruited from a healthy subject
pool within a collaborative research center (CRC TRR-58, ﬁrst and second
funding period, see Supplementary Table S1 for sample descriptives) and
partly included in the GWAS analyses reported in.1 However, this sample
originated from a different project within the CRC TRR-58, using a complex
cue and context conditioning procedure. For subjects already included in
the previous GWAS analysis we present new data on associations between
GLRB genetic variants and brain function (n= 48) and morphology
(n=416). In addition, we present data of a further sample on GLRB
dependent variation of startle habituation (n=105, of which seven
subjects were included in the previous GWAS). Subjects were screened
for psychiatric conditions via the mini-international neuropsychiatric
interview,22 and excluded if screening for any lifetime mental disorder
was positive. They provided written informed consent and protocols were
approved by the General Medical Council of the State of Hamburg.
Sample 2: This healthy control group sample was recruited within the
national research network PANIC-NET23 (Supplementary Table S1) and not
part of the previous report. Four centers (Aachen, Berlin-Charité, Dresden,
Münster) participated in a longitudinal functional magnetic resonance
imaging (fMRI) study that aimed to detect neuroplastic changes following
exposure-based cognitive-behavioral therapy in PD with AG. Quality
controlled fMRI data from n=60 controls24 were included from whom
genotype information on rs7688285 was available in n= 38 subjects.
Subjects were free of lifetime mental disorders as evidenced by the
Composite International Diagnostic Interview (CAPI-WHO-CIDI; DIAX-CIDI
version).25 After complete description of the study, subjects provided
informed written consent. The study had been approved by the ethics
committees of all participating centers.
Genotyping
Genotyping based on blood samples was performed with Sequenom's
MassArray system (Sequenom, San Diego, CA, USA), as described
previously.1 Focusing on rs7688285 as main SNP of interest, the Risk
group was deﬁned as carrying at least one risk (A) allele (G/A). Complying
with the previous report,1 rs7688285 and three further GLRB variants
(rs17035763: G/A with A allele as risk allele, rs191260602: A/G with G allele
as risk allele, and rs78726293: T/A with A allele as risk allele) were used for
the Combined GLRB Risk group analyses (see Supplementary Information).
Combined Risk group status was deﬁned as carrying at least one risk allele
out of the four SNPs.
Data acquisition and analysis pathways
Sample 1. The fMRI assessment employed a combined cue and context
fear conditioning paradigm (for details see26–28). Subjects viewed a
sequence of three different rooms (45 s each) as context CSs, which were
assigned counterbalanced to a cue conditioning (predictable: p), a context
conditioning (unpredictable: u) or a safe condition (s). During ﬁxed time
windows, three different symbols that served as cue CSs (5 s) were
superimposed on the assigned room. A black screen with a white ﬁxation
cross served as inter-trial interval for 6–8 s (mean 7 s). An individually
adjusted electro-tactile stimulus served as US. To mirror experimental
designs reported in1 and in sample 2, only responses based on cued, not
context fear were considered. Subjective ratings and mean skin
conductance reactions across all cue onsets were analyzed by an analysis
of variance (ANOVA) with CS-type as within-subject variable and genotype
as between-subject variable across all blocks. Details on data acquisition,
post-processing, and response deﬁnition for skin conductance reaction
have been reported previously.26–28 Data of seven subjects were excluded
because their proportion of zero or missing responses exceeded a
threshold of 66% during the full fear acquisition phase. An α level of
Po0.05 was considered signiﬁcant and Greenhouse–Geisser correction
was applied if necessary.
Functional and structural magnetic resonance imaging data were
acquired on a 3 T MRI scanner (MAGNETOM Trio, Siemens, Erlangen,
Germany). For fMRI, 38 continuous axial slices (2 mm thick, 1 mm gap)
were acquired using a T2*-sensitive gradient echo-planar imaging (EPI)
sequence (repetition time (TR): 2.34 s; echo time (TE): 26 ms; ﬂip angle: 80°;
ﬁeld of view (FOV): 220 × 220 mm, 2 × 2 mm in-plane resolution) in three
sessions (229 volumes/ ~ 9 min each) using a 32-channel head coil
(generalized auto-calibrating partially parallel acquisitions, GRAPPA-factor
2). To account for T1 equilibrium effects, the ﬁrst four volumes of each time
series were discarded. fMRI preprocessing included realignment, unwarp-
ing, co-registration and normalization (using DARTEL29) with SPM8 (http://
www.ﬁl.ion.ucl.ac.uk/spm/) running on MATLAB2013a (The MathWorks,
Natick, MA, USA) smoothed with a 6 mm full-width at half maximum
(FWHM) isotropic Gaussian kernel. For ﬁrst-level analyses, data were
analyzed within the framework of the general lineal model for differences
in general and differential cued fear responses (that is, CS+ & CS− ; CS+ vs
CS− ). Linear models for each of the three sessions included block
regressors for three contexts (PCXT, UCXT, SCXT) and one block regressor
for the rating phase. Event-regressors were included for three cue- (PCue,
UCue, SCue) and US-onsets and convolved with the canonical hemody-
namic response function. Parameter estimates (β− ) images were
calculated and linearly combined for contrasts for main effect responses
(CS+ & CS− ), as well as differential responses (CS+ vs CS− ). As the
previous study1 reported ﬁndings particularly during early acquisition, we
computed ﬁrst-level contrasts for early acquisition (session one only), late
acquisition (session two and three), as well as full acquisition (all sessions).
Second-level group analyses were performed using general lineal model
analyses for early, late and full acquisition by two-sample t-test designs.
Contrasts of interest included the main effect of group (Risk: AG, GG carriers vs
No-Risk: GG carriers) and the interaction effect of group * CS (CS+ vs CS− ).
Because of signiﬁcant group differences in mean age (see Supplementary
Table S1), second-level analyses included age as regressor of no interest.
The following regions of interest (ROI) were used based on the automatic
anatomical labeling atlas30 and the Tailarach Daemon lobes as imple-
mented in the wfu pickatlas:31 brainstem (medulla, pons, and midbrain),
thalamus, amygdala, hippocampus, insula, ACC, medial prefrontal cortex
(superior medial frontal gyrus, medial orbitofrontal gyrus), supplementary
motor areal and precentral gyrus. Small volume corrections were based on
a cluster forming threshold of Po0.001 and a family-wise error threshold
of Po0.05. Beta values from signiﬁcant peak voxels were extracted for bar
graph visualization.
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Details of structural (s) MRI for brain morphometry have been reported
previously.27 High-resolution T1-weighted images (1 × 1× 1 mm) were
acquired using a magnetization prepared rapid gradient echo sequence
(MPRAGE) using a 12- or a 32-channel head coil (coil number was included
as covariate). Grey matter differences were analyzed using the voxel-based
morphometry (VBM) toolbox (VBM8, version 435, www.http://dbm.neuro.
uni-jena.de/ vbm/) as provided for SPM8. Default settings included a ‘non-
linear only’ modulation of the grey matter (GM). Pre-processed images
were smoothed with a Gaussian kernel of 8 mm FWHM. Analysis of the
covariance between the images identiﬁed no images as outliers (mean−
2 × s.d.). Correction of multiple comparisons followed the regions of
interest approach of the fMRI analyses above. An additional exploratory
whole-brain analysis was computed using an uncorrected threshold of
Po0.001 and a minimum cluster size of k4=15. Where appropriate,
covariates were added if groups differed in demographic or personality
properties (for example, ASI sum score).
Startle reactions were measured by recording electromyographic activity
over the orbicularis oculi muscle beneath the left eye using miniature Ag/
AgCl electrodes. A 50 ms burst of 95 dB(A) white noise with an
instantaneous rise-time was presented binaurally via headphones (Senn-
heiser, Wedemark, Germany) as startle-eliciting stimulus. In correspon-
dence with,1 startle habituation was assessed for 12 blink responses during
inter-trial intervals interspersed during passive viewing of emotional
pictures in an affective startle modulation paradigm. Although the task was
conceptually similar to the paradigm employed by the previous report,
subtle differences with respect to timings, experimental breaks, or selected
stimulus material exist. An ANOVA testing for a direct interaction effect of
the within- (time block) and the between-subject (genotype) factors was
computed. All behavioral and psychophysiological data of the sample were
analyzed using SPSS 22 (IBM, Armonk, NY, USA) for Windows.
Sample 2. A differential fear conditioning and extinction task was
employed that has been described elsewhere.32 It consisted of three
phases (familiarization (F) with 16 trials; acquisition (A) with 32 trials and
extinction (E) with 16 trials of each CS (colored geometrical forms);
presentation time: 2000 ms with a variable inter-trial interval of 4.785 to
7.250 s) and an aversive tone (white noise; 100 ms) as US between 70 and
105 dB. In the acquisition, the US was pseudorandomly paired with one of
the CSs (counterbalanced between subjects; partial reinforcement rate of
50%), resulting in equal proportions of CS+paired and CS+unpaired trials
of which only CS+unpaired trials were used to avoid confounding effects
between CS+ and US processing. Structural data with sufﬁcient high-
resolution were not available for sample 2. After each phase, valence and
arousal ratings using the Self-Assessment Manikin33 for CSs were obtained
using a ﬁve-point Likert Scale (for valence: 1 = ‘very unpleasant’ to 5 = ‘very
pleasant’ and for arousal: 1 = ‘not arousing’ to 5 = ‘very arousing’). Two
subjects that rated the US aversiveness below 4 (on a 10-point Likert scale)
were excluded from analyses. Because of technical problems ratings of one
subject were missing. Task duration was 16:49 min. Stimuli were presented
by MR-compatible LCD goggles or back projection systems and standard
headphones using Presentation 11 (Neurobehavioral Systems, http://www.
neurobs.com). Ratings were analyzed using a three-factorial analysis of
covariance with the between-subjects factor ‘risk group’, the within-
subjects factors ‘phase’ and ‘CS’ and Beck Depression inventory II (BDI II)34
scores as covariate, with Po0.05 serving as the statistical threshold. If
sphericity assumptions were violated, Greenhouse-Geisser correction was
applied.
Images were acquired using 3 T Philips Achieva (Aachen and Münster),
3 T Siemens Trio (Dresden), and 3 T General Electric Healthcare (Berlin)
scanners. Five-hundred and ﬁve axial functional images (EPI, matrix
64 × 64, 30 slices interleaved, FOV=230, voxel size = 3.6 × 3.6 × 3.8 mm,
TE= 30 ms, TR= 2 s), covering the whole brain were recorded. Images were
analyzed using SPM5 implemented in MATLAB 6.5. The ﬁrst ﬁve volumes
were discarded to minimize T1 saturation effects. Data were ﬁltered to
1/128 Hz to remove low-frequency noise. Functional images were slice-
time corrected, temporally and spatially aligned and normalized into
standard stereotactic space (2 × 2× 2 mm). To account for differences in
intrinsic smoothness between scanners, an iterative smoothness equaliza-
tion procedure35 was performed using a target smoothness of 12 mm
FWHM Gaussian isotropic kernel (~ 8 mm FWHM in a normal smoothing
procedure). A detailed description of measures for quality control is given
in.32 At ﬁrst level, realignment parameters were included as regressors of
no interest. The BOLD response for each event type (CS+paired, CS
+unpaired, CS-, US) and phase (F, A, E) was modeled by the canonical
hemodynamic response function within the framework of the general
linear model. Parameter estimates (ß-) and t-statistic images were
calculated. At the second level, a group analysis was performed by
entering contrast images into a ﬂexible factorial analysis. FMRI center
variables and the BDI II were introduced as covariates of no interest.
Contrasts of interest included the main effect of group (Risk: AG, GG
carriers vs No-Risk: GG carriers) during acquisition and - in order to test for
the speciﬁcity of effects for fear learning - extinction, as well as the
interaction effect of group×CS (CS+ unpaired vs CS− ) for each
experimental phase. Corresponding to,1 we further split acquisition as
well as extinction into early vs late parts. Two-sample t-tests were used in
order to localize the direction of effects. Identical ROI analyses were
performed as in sample 1. For exploratory whole-brain analyses and in line
with previous analyses of this dataset,24,32,36 a Monte-Carlo simulation was
conducted to establish an appropriate voxel contiguity threshold.37
Assuming an individual voxel type I error of Po0.005, a cluster extent
of 142 contiguous resampled voxels was indicated as sufﬁcient to correct
for multiple voxel comparisons at Po0.05. Beta values from signiﬁcant
peak voxels were extracted for bar graph visualization.
RESULTS
GLRB modulation of fear network activation
Main effect of GLRB group. Sample 1. While cue-related acquisi-
tion of fear during fMRI was indicated by a signiﬁcant main effect
of CS-type for subjective ratings and skin conductance reactions,
no main or interaction effect with GLRB risk genotype was
observed (Supplementary Table S2 and Supplementary Figure S1).
On a neural level, a main effect was observed for the GLRB Risk
group during early fear acquisition in the left (anterior) insula /
frontal operculum area (x, y, z: −42, 14, 6; t= 4.20, P= 0.027;
Figure 1) and mid-brain (x, y, z: − 8, − 20, − 16; t= 4.19, P= 0.030).
During the full course of acquisition, increased activation was
observed for GLRB risk carrier in right insula (x, y, z: 34, − 18, 20;
t= 3.90, P= 0.049) and left amygdala (x, y, z: − 16, − 2, − 12; t= 3.92,
P= 0.007). Similar ﬁndings were obtained when using the
Combined Risk group deﬁnition as in the previous report1 (see
Supplementary Table S6 for sample characteristics and S7 for fMRI
results).
Sample 2. While subjective ratings indicated successful fear
conditioning as shown by a signiﬁcant time ×CS interaction effect
for valence and a strong, yet insigniﬁcant trend for arousal, no
main or interaction effects with GLRB were observed
(Supplementary Table S3 and Supplementary Figure S2).
On a neural level, risk allele carriers showed enhanced
activation in the right anterior insula compared with the no-risk
group. This effect was equally driven by acquisition and extinction
phases and was irrespective of stimulus type (Table 1, Figure 1).
Similar ﬁndings were obtained for the Combined Risk group
deﬁnition (Supplementary Tables S6 and S10).
Interaction effect GLRB group × CS. Sample 1. Discrimination
between CS+ and CS− was on a neural level attenuated for the
Risk group compared to the No-Risk group in the left amygdala,
hippocampus, and insula during the full course of fear acquisition.
This attenuation was further observed in the right anterior
cingulate, medial orbitofrontal and superior frontal gyrus and
insula during early acquisition. During late acquisition, however,
stronger CS+4CS- discrimination for the Risk group was observed
in the right thalamus (Table 2, Figure 2), while for the No-Risk
group stronger discrimination was observable in the hippocam-
pus. Partly overlapping ﬁndings were found for the Combined Risk
group deﬁnition (Supplementary Table S9).
Sample 2. Analyses yielded an interaction between group and
CS that was speciﬁc for fear acquisition, while no effects were
found for the extinction. During early acquisition and in line with
data from sample 1, subjects with at least one risk allele showed
enhanced defensive responding encompassing neural activation
in areas such as the left insula, bilateral ACC, amygdala, thalamus,
and right midbrain towards presentation of the CS- compared to
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the CS+, while the No-Risk group showed a normal pattern of
conditioning (stronger responses towards the CS+ than the CS-).
During late acquisition, this pattern reversed and showed neural
indicators of sustained differential conditioning in the Risk group
towards the CS+ while the No-Risk group showed decreased
differential CS responding (Table 2, Figure 2). No differential
activation was found during the extinction phase. Similar ﬁndings
were obtained for the Combined Risk group deﬁnition
(Supplementary Table S11).
GLRB modulation of brain morphology
Sample 1. Genotype-dependent structural alterations were
observed in regions of interest as increased grey matter volume
for the Risk group in the right superior medial frontal gyrus and
Table 1. Main effect of GLRB Risk group on brain activation patterns during fear acquisition and extinction in sample 2 (cluster peak voxels are given)
Contrast/region Side Voxels x y z t Pa
Overall: Risk4No-Risk
Insula R 2387 34 14 14 4.49 o0.001
Insulab L 33 − 44 6 6 4.42 0.048
Precentral gyrus L 554 − 42 − 8 46 4.26 o0.001
Superior parietal gyrus (2.83 mm dev.) R 731 24 − 52 48 3.91 o0.001
Precentral gyrusb R 164 48 − 2 46 3.62 0.040
Middle occipital gyrus (2.00 mm dev.) R 204 40 − 68 0 3.54 o0.001
Inferior frontal operculum L 276 − 44 8 6 3.42 o0.001
Superior frontal gyrus R 179 28 − 8 64 2.98 0.002
Overall: No-Risk4Risk No differential activation
Full acquisition: Risk4No-Risk
Middle occipital gyrus R 375 40 − 68 2 4.36 o0.001
Precentral gyrus L 284 − 42 − 8 46 3.97 o0.001
Rolandic operculum (4.00 mm dev.) R 805 42 − 16 26 3.84 o0.001
Precentral gyrus R 354 38 − 22 70 3.59 o0.001
Insula R 660 32 14 14 3.41 o0.001
Full acquisition: No-Risk4Risk No differential activation
Full extinction: Risk4No-Risk
Precuneus (2.00 mm dev.) R 993 20 − 40 46 4.41 o0.001
Insula (2.00 mm dev.) R 801 32 26 14 4.27 o0.001
Caudate nucleus (2.00 mm dev.) R 144 16 − 10 26 3.81 o0.001
Ponsb R 28 4 − 22 − 32 3.66 0.017
Insula L 385 − 40 6 − 4 3.50 o0.001
Amygdalab L 2 − 22 2 − 24 3.49 0.006
Precentral gyrus L 225 − 40 − 10 52 3.09 0.001
Full extinction: No-Risk4Risk No differential activation
Abbreviations: dev, Deviation (in mm) from the identiﬁed anatomical structure using anatomic automatic labeling (aal); L, left; R, right; voxel, number of voxels
per cluster; x, y, z, MNI coordinates. aWhole brain results at Po0.005 (uncorr.) with a minimum cluster size of 142 contiguous voxels, indicating to correct for
multiple comparisons at Po0.05. bSmall volume correction using aal masks (family-wise error correction at Po0.05) with a cluster forming threshold of
Po0.001. Risk group status was deﬁned as carrying at least one risk allele (A allele).
Figure 1. Main effect of GLRB Risk group during fear conditioning in sample 1 (a; n= 48) and sample 2 (b; n= 38). In both samples, the Risk
groups showed enhanced overall activation of the right anterior insula. While this effect was restricted to the early acquisition in sample 1,
Risk allele carriers from sample 2 showed sustained activation throughout the acquisition (early and late) and extinction. Risk group status was
deﬁned as carrying at least one risk allele (A allele). CS+, stimulus that was followed by the unconditioned stimulus; CS− , stimulus that was
never followed by the unconditioned stimulus; R, right. Threshold at P= 0.005 for illustrative purposes.
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Table 2. Interaction effect GLRB Risk group and conditioned stimulus (CS+ vs CS− ) on brain activation patterns during fear acquisition
Contrast/region Side Voxels x y z t P
Sample 1
Full acquisition: Risk4No-Risk (CS+4CS− ) No differential activation
Full acquisition: Risk4No-risk (CS-4CS+)
Amygdala L 13 − 30 − 4 − 18 4.39 0.002
Hippocampus L 13 − 26 − 14 − 24 3.93 0.016
Hippocampus L 13 − 28 − 8 − 22 3.54 0.043
Early acquisition: Risk4No-Risk (CS+4CS− ) No differential activation
Early acquisition: Risk4No-Risk (CS−4CS+)
Precentral gyrus L 38 − 58 − 2 22 4.21 0.018
Anterior cingulate gyrus R 4 4 34 2 3.95 0.025
Middle cingulate gyrus R 7 2 − 6 30 3.80 0.036
Late acquisition: Risk4No-Risk (CS+4CS− )
Thalamus R 14 18 − 12 8 4.33 0.009
Late acquisition: Risk4No-Risk (CS-4CS+) No differential activation
Sample 2
Full acquisition: Risk4No-Risk (CS+4CS− ) No differential activation
Full acquisition: Risk4No-Risk (CS−4CS+)
Thalamusa L 28 0 − 20 6 4.08 0.003
Thalamusa R 10 2 − 20 6 3.81 0.007
Early acquisition: Risk4No-Risk (CS+4CS− ) No differential activation
Early acquisition: Risk4No-Risk (CS−4CS+)
Middle temporal gyrus R 271 58 0 − 20 5.37 o0.001
Postcentral gyrus R 4982 28 − 48 − 72 4.68 o0.001
Middle occipital gyrus L 724 − 34 − 85 36 4.58 o0.001
Thalamus L 364 0 − 20 5 4.57 o0.001
Thalamusa R 48 2 − 20 6 4.43 0.001
Amygdala L 4114 − 24 − 4 − 16 4.28 o0.001
Superior temporal gyrus L 785 − 58 − 5 0 3.90 o0.001
Hippocampusa L 114 − 24 − 8 − 18 3.96 0.005
Postcentral gyrus R 453 66 − 18 38 3.78 o0.001
Anterior cingulate gyrusa L 84 0 42 4 3.69 0.016
Anterior cingulate gyrusa R 55 2 42 4 3.73 0.012
Anterior cingulate gyrusa R 12 8 8 28 3.68 0.014
Supplementary motor areaa L 22 2 8 44 3.65 0.022
Supplementary motor area R 189 8 − 16 76 3.62 o0.001
Anterior cingulate gyrusa L 3 2 18 − 10 3.50 0.030
Anterior cingulate gyrusa R 41 4 28 28 3.52 0.024
Insulaa L 14 − 26 10 − 20 3.52 0.035
Superior medial frontal gyrusa R 10 2 46 2 3.51 0.038
Anterior cingulate gyrusa L 49 0 22 26 3.47 0.033
Middle frontal gyrus R 211 30 50 18 3.45 o0.001
Medial orbitofrontal gyrusa R 1 0 22 − 12 3.44 0.020
Midbraina R 15 12 − 28 − 12 3.43 0.046
Amygdalaa R 10 24 4 − 20 3.28 0.014
Medial orbitofrontal gyrusa L 2 − 4 22 − 14 3.20 0.035
Late acquisition: Risk4No-Risk (CS+4CS− )
Temporal pole R 445 40 8 − 38 4.31 o0.001
Middle temporal gyrus R 503 52 − 68 2 4.24 o0.001
Vermis 4 5 – 2983 6 − 54 2 4.09 o0.001
Rolandic operculum R 1251 50 − 14 18 3.92 o0.001
Inferior frontal operculum R 95760 60 14 14 3.88 o0.001
Ponsa R 42 10 − 32 − 26 3.87 0.010
Anterior cingulate gyrus L 735 − 2 22 26 3.86 o0.001
Middle frontal gyrus R 178 26 40 28 3.85 o0.001
Superior frontal gyrus R 352 34 − 2 68 3.83 o0.001
Anterior cingulate gyrusa R 29 2 20 28 3.65 0.016
Middle temporal gyrus (2.00 mm dev.) R 438 48 − 16 − 16 3.62 o0.001
Cuneus R 753 14 86 28 3.58 o0.001
Amygdalaa R 8 32 2 − 30 3.47 0.008
Hippocampus (2.83 mm dev.) L 161 − 38 10 − 18 3.38 o0.001
Hippocampusa R 4 42 − 16 − 14 3.30 0.041
Insula (2.00 mm dev.) R 278 28 20 − 8 3.26 0.001
Middle frontal gyrus L 149 −26 14 46 3.17 0.001
Late acquisition: Risk4No-risk (CS−4CS+) No differential activation
Abbreviations: CS: conditioned stimulus; CS-: CS that is never followed by an unconditioned stimulus (US); CS+: CS that is always followed by the US (sample 1)
or with a reinforcement rate of 50% (sample 2; only unpaired CS+ were included in the analysis); L: left; R: right; voxel: number of voxels per cluster; x, y, z: MNI
coordinates; dev.: deviation (in mm) from the identiﬁed anatomical structure using anatomic automatic labeling (aal). Risk group status was deﬁned as
carrying at least one risk allele (A allele). Sample 1: ROI peak voxels are given. Small volume correction in pre-deﬁned ROI analyses (family-wise error correction
at Po0.05) with a cluster forming threshold of Po0.001. Sample 2: Whole-brain results at Po0.005 (uncorr.) with a minimum cluster size of 142 contiguous
voxels, indicating to correct for multiple comparisons at Po0.05. aSmall volume correction using aal masks (family-wise error correction at Po0.05) with a
cluster forming threshold of Po0.001. No signiﬁcant clusters were detected for the extinction phase (full, early, or late).
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Figure 2. Interaction effect of GLRB Risk group and conditioned stimuli during fear conditioning in sample 1 (a; n= 48) and sample 2 (b;
n= 38). During early acquisition (left), Risk allele carriers showed no (a; sample 1) CS differentiation or even inverted differentiation favoring
the CS− (b; sample 2). During late acquisition (right), this pattern reversed with enhanced responding towards the CS+ compared to the CS-
in the Risk group only. Risk group status was deﬁned as carrying at least one risk allele (A allele). CS+: stimulus that was followed by the
unconditioned stimulus; CS-: stimulus that was never followed by the unconditioned stimulus. R, right; L, left. Threshold at P= 0.005 for
illustrative purposes.
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left precentral gyrus. Results of the exploratory whole brain
analysis revealed increased grey matter volume for the Risk group
in the precentral and superior medial frontal gyrus and middle
frontal gyrus, middle temporal gyrus, superior temporal gyrus and
angular gyrus while reductions were observed in the planum
polare (Figure 3, Supplementary Table S4). Findings encompassing
the right superior medial frontal gyrus, left precentral gyrus and
left middle frontal gyrus (Risk4No-Risk), as well as right planum
temporale (No-Risk4Risk) were replicated in the combined risk
group analysis (Supplementary Table S9).
GLRB modulation of startle reﬂex reactivity
Sample 1. The interaction between time x genotype-group did not
reveal differential decrements in responding between both
genotype groups (F (1,103) = 0.526, P= 0.470, see Supplementary
Table S5 for statistical details). The startle effect could not be
replicated using the combined risk group deﬁnition
(Supplementary Table S12).
DISCUSSION
Recent ﬁndings1 reported strong translational evidence for glycine
neurotransmission as a modulator of the brain’s evolutionary old
defensive system and provided a strong, biologically plausible
candidate intermediate phenotype of defensive reactivity within
the domain of negative valence and arousal systems as laid out in
the RDoC matrix.
The present paper conceptually replicated and extended these
initial ﬁndings on the behavioral, neurofunctional and neurostruc-
tural level, yielding the following major ﬁndings: converging
evidence was found for increased anterior insular activation in
GLRB risk allele carriers (rs7688285) in both samples despite two
procedurally different fear conditioning tasks, thus supporting the
initial report.1 Also in line, we showed increased differential
conditioning (CS+4CS− ) during late acquisition in the GLRB risk
groups on a neurofunctional level. Extending previous evidence,
GLRB risk allele carriers showed an inverse pattern of responding
by increased processing of the CS− compared with the CS+
during the early acquisition. These ﬁndings were also observed
when using an alternative Combined Risk group deﬁnition
previously employed1 (see Supplementary Information), thus
further supporting their robustness. Results on startle reactivity
were inconclusive and demand further investigations.
General reactivity of the brain’s defensive system as a function of
the GLRB genotype
The insular cortex serves as a cortical representation of upstream
visceral information.38 Meta-analytic evidence assigns a central
role of the anterior insula to fear conditioning in healthy
subjects11,12 and implicates the insula in pathological states of
anxiety.39 We here provide converging evidence that allelic
variation in the GLRB gene is associated with stronger activation
of the anterior insula during fear conditioning, being in line with
the previous report.1 Beyond this insular focus, some other areas
of interest from this report, including the precentral gyrus,
amygdala, and basal ganglia, could be replicated in sample 2,
while replication failed for other brain regions such as the
thalamus or hippocampus, possibly due to procedural differences
in study designs. Noteworthy, stronger pons activation in GLRB risk
carriers was observed in sample 2 during extinction. Volume
enlargement of the superior medial frontal and precentral gyrus
was detected in the structural dataset, thus providing preliminary
evidence for GLRB modulation of brain structure. Despite an
overlap of morphometric differences between genotype groups in
these areas, functional activation differences observed in the same
ROIs are unlikely to be attributed to structural differences, as they
rely on differential within-subject contrasts (CS+4CS− ).
Glycine receptors play a major role for inhibitory neurotrans-
mission. Single-point mutations in genes encoding glycine
receptors, including its beta receptor subunit (GLRB), have been
associated with human hyperekplexia, or startle disease.40,41 This
condition is characterized by exaggerated startle reﬂexes in
response to sudden unexpected auditory, visual or tactile stimuli.
On a translational level, this phenotype is conﬁrmed by the spastic
mouse (featuring a substantial reduction of Glrb), showing
exaggerated startle reactions42,43 as a basic indicator of defensive
system reactivity. Evidence on attenuated startle habituation in
GLRB risk allele carriers in the present analysis was however
negative. Paralleling previous ﬁndings1 on a descriptive level, we
observed different slopes of startle habituation according to GLRB
allelic variation. Single-trial data (Supplementary Figure S4)
suggest higher initial startle reactivity in risk-allele carriers that
might manifest as attenuated habituation in blocked analyses.
Future studies are needed to elucidate the underlying processes
of GLRB dependent startle reactivity in depth.
Being more ancient than the GABA system, glycine receptors
are mainly distributed in evolutionary older brain regions
encompassing the spinal cord, brainstem including the midbrain,
and olfactory bulb,44,45 but recent transcript analyses detected
GlyB receptors also in the frontal cortex, hippocampus and
striatum.46 As shown in the previous report1 genotype-speciﬁc
differences of the promoter region risk variant rs7688285 on
mRNA expression levels were found in the midbrain, where the
minor, risk (A)-allele increased the mean expression of GLRB
signiﬁcantly by 1.34 fold. Neither in the forebrain nor in the
amygdalae, rs7688285 affected mRNA expression. Transcript and
protein determination of Glrb in spastic mice pointed to low
transcript expression of Glrb particularly in the cortex and
thalamus.1 We assume that our ﬁndings reﬂect a bottom-up
modulatory effect on higher-order defensive system components
by more hard-wired reﬂexes in the brainstem (as reﬂected by pons
and midbrain activation in sample 2), which is corroborated by
high-resolution diffusion imaging47 and resting-state48 fMRI
Figure 3. Volumetric group effect for Risk vs No-Risk group from sample 1 as assessed by exploratory voxel-based morphometry. Display
threshold at P= 0.001, ko = 15. Risk group status was deﬁned as carrying at least one risk allele (A allele). R, right; L, left.
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studies showing that the insula is functionally connected to the
brainstem and that coma-causing brain stem lesions are
associated with a dissociation of this network.48
Altogether with the previous report, we provide converging
evidence from a total of three different samples on the effect of
allelic variation in the GLRB gene for enhanced activation of the
anterior insula as a core component of higher-order threat-
processing systems. However, the GLRB Risk group did not report
higher symptoms of anxiety or showed different subjective or
autonomic conditionability. This observation is in line with present
ﬁndings representing an intermediate phenotype, where variance
in defensive system responding is related to allelic variation of the
GLRB, yet does not lead to symptoms of pathological anxiety. We
thus provide further support for the role of GLRB, which is listed
under the arousal gene list in the RDoC matrix, for a neurofunc-
tional intermediate phenotype associated with enhanced defen-
sive system reactivity that may increase the vulnerability to
develop pathological forms of anxiety.
Differential reactivity of the brain’s defensive system as a function
of the GLRB genotype
Fear conditioning is a basic learning mechanism that allows the
organism to ﬂexibly adapt to environmental dangers. Importantly,
during differential fear conditioning, the organism learns to
process the CS+ as a threat signal, while associating the
unreinforced CS- with safety.49 Depending on the stimulus
presented, subjects will either activate the defensive system
towards the CS+, or inhibit it towards the CS-. Despite procedural
differences across the fear conditioning tasks, we observed
surprisingly strong evidence for enhanced CS discrimination (CS
+4CS-) in GLRB risk allele carriers from both samples particularly
during the late phase of fear conditioning in fear processing
regions such as the thalamus (sample 1) or amygdala, hippocam-
pus, ACC, and insula (sample 2), showing an overlap particularly in
the insula and thalamus with previously reported ﬁndings.1
Extending these, we additionally observed an inverse effect
during early fear conditioning: here the GLRB risk group showed
impaired CS- discrimination (sample 1: precentral gyrus and ACC)
or even enhanced responding towards the CS− (sample 2: ACC,
insula, amygdala, thalamus, and midbrain) that resembles
impaired fear inhibitory learning as reported for pathological
states of anxiety. While the main group effect of GLRB was driven
by enhanced responding in the insula during both acquisition and
extinction (sample 2), GLRB effects on differential conditioning
were observed during fear learning only, thus pointing towards a
speciﬁcity in modulating the acquisition of conditioned fear, but
possibly not its recall or fear inhibitory learning (as induced during
extinction training). Evidence from fear conditioning studies50
suggests that anxiety disorders (and particularly PD51) are not
characterized by enhanced reactivity towards the CS+, but rather
by attenuated fear inhibition in the face of a safety signal leading
to reduced discrimination between both CSs. Using fMRI,
enhanced activation of defensive circuit networks in response to
a safety signal has been reported as a pathophysiological feature
of PD24,52 and as a marker of non-response towards exposure-
based treatment36 that is based on fear-inhibitory learning,
reﬂecting the relevance of safety signal processing for the
etiopathogenesis of anxiety disorders. Given further evidence on
the relevance of GLRB allelic variation regarding the underlying
etiopathogenesis of anxiety disorders, it could represent an
additional source in explaining altered patterns of fear condition-
ing, thus offering potential to stratify patient subgroups to
individually tailored, novel therapeutic strategies (for example,
fostering discriminatory learning).
Study limitations
Owing to the post-hoc nature of this analysis, particularly sample 2
was possibly underpowered for subgroup analyses. However, in
yielding a signiﬁcant difference, these ﬁndings speak in favor of a
large effect size of rs7688285 on brain activation which could be
informative to base power calculations of future a priori studies
upon. As not enough AA homozygote subjects were available in
the fMRI samples, no dose–response relationship on the number
of risk alleles could be investigated. fMRI and startle data were not
available on the same sample, thus precluding multimodal
comparisons across different units of analyses. Recent technical
advances for combined assessments will allow for more ﬁne-
grained investigations of defensive system functioning in future
studies.53 Data on brain morphology with sufﬁcient resolution
were only available for sample 1, but not sample 2 (due to
restrictions in this multicenter study). Findings may serve as a
starting point for further replication approaches on brain
morphometric effects of GLRB. Although preliminary ﬁndings in
the pons and midbrain were observed, it should be noted that the
scanning parameters of both studies were not optimized for brain
stem imaging, e.g. regarding pulsatory artifacts. Animal studies
may furthermore inform about the interplay of these hierarchically
organized systems and the modulatory function of the glycine
receptors.
CONCLUSION
Representing one of the ﬁrst GWAS-conﬁrmed ﬁndings related to
the phenotype of PD54–56 and AG, converging evidence for GLRB
allelic variation in defensive reactivity was derived from a large-
scale translational approach, cross-cutting different levels of
analyses. Of note, the robustness of this ﬁnding is demonstrated
by consistent associations across different experimental para-
digms and recording sites. As such, glycine-dependent neuro-
transmission may open up new avenues for mechanistic research
on the etiopathogenesis of fear and anxiety disorders.
CONFLICT OF INTEREST
TK received fees for educational programs from Janssen-Cilag, Eli Lilly, Servier,
Lundbeck, Bristol Myers Squibb, Pﬁzer, and Astra-Zeneca; travel support/sponsorship
for congresses from Servier; speaker’s honoraria from Janssen-Cilag; and research
grants from Pﬁzer and Lundbeck. H-UW has been member of advisory boards of
several pharmaceutical companies. He received travel reimbursements and research
grant support from Essex Pharma, Sanoﬁ, Pﬁzer, Organon, Servier, Novartis,
Lundbeck, Glaxo Smith Kline. VA is member of advisory boards and/or gave
presentations for the following companies: Astra-Zeneca, Janssen-Organon, Lilly,
Lundbeck, Servier, Pﬁzer, and Wyeth. He also received research grants from Astra-
Zeneca, Lundbeck, and Servier. He chaired the committee for the ‘Wyeth Research
Award Depression and Anxiety’. AS received research funding from the German
Federal Ministry of Education and Research, the European Commission (FP6) and
Lundbeck, and speaker honoraria from Astra-Zeneca, Boehringer Ingelheim, Eli Lilly &
Co, Lundbeck, Pﬁzer, Wyeth, and UCB. Educational grants were given by the
Stifterverband für die Deutsche Wissenschaft, the Berlin Brandenburgische Akademie
der Wissenschaften, the Boehringer Ingelheim Fonds and the Eli Lilly International
Foundation. AR has received a research grant from Medice, and speaker’s honoraria
from Medice and neuraxpharm. The remaining authors declare no conﬂict of interest.
ACKNOWLEDGMENTS
Sample 1
Funding: This work was part of the Collaborative Research Center ‘Fear, Anxiety,
Anxiety disorders’ which is funded by the Deutsche Forschungsgemeinschaft (SFB
TRR58 subprojects B06, B07, and Z02).
We thank DS, RS, and LK for help with data acquisition of the recruitment sample.
The fear conditioning task (study 1), the morphological study, as well as the affective
startle paradigm were approved by the medical advisory board (Ethikkommission der
Ärztekammer Hamburg; PV2755, PV4118, PV3378).
Sample 2
GLRB modulation of defensive reactivity
U Lueken et al
8
Translational Psychiatry (2017), 1 – 10
Funding/Support: This work is part of the German multicenter trial ‘Mechanisms of
Action in CBT (MAC)’. The MAC study is funded by the German Federal Ministry of
Education and Research (BMBF; project no. 01GV0615; neuroimaging study: project
no. 01GV0611) as part of the BMBF Psychotherapy Research Funding Initiative.
Centers: Principal investigators (PI) with respective areas of responsibility in the
MAC study are VA (Münster: Overall MAC Program Coordination), H-UW (Dresden:
Principal Investigator (PI) for the Randomized Clinical Trial and Manual Development),
AH (Greifswald: PI for Psychophysiology), ALG (Münster: PI for Psychophysiology and
Panic subtypes), AS (Berlin: PI for Experimental Pharmacology), TK (Marburg: PI for
functional neuroimaging), and JD (Würzburg: PI for Genetics). Additional site directors
in the RCT component of the program are GWA (Würzburg), TF and LF (Berlin-
Adlershof), and TL (Bremen).
Data Access and Responsibility: All principle investigators take responsibility for the
integrity of the respective study data and their components. All authors and co-
authors had full access to all study data. Data analysis and manuscript preparation
were completed by the authors and co-authors of this article, who take responsibility
for its accuracy and content.
Acknowledgements and staff members by site: Greifswald (coordinating site for
Psychophysiology): CM, JR, SR, MvR; B-C (coordinating Center for Experimental
Pharmacology): HB, AS, MS, AW; B-A: IS; Münster (Overall MAC Program Coordination,
Genetics and Functional Neuroimaging): AB, KD, AE, CK, BP, CU, PZ; Münster
(coordinating site for psychophysiology and subtyping): JE, SK, FR, AV-E; Marburg/
Aachen (coordinating center for functional neuroimaging): BD, SE, TF, SG, SG, Aansen,
TK, IR, NV-F; Dresden (coordinating site for data collection, analysis, and the RCT): FE,
CF, ATG, CH, SH, MH, UL, PN, SP, DW; Würzburg Psychiatry Department (coordinating
center for genetics): AR, CG; Würzburg Psychology Department: JD, HE, ABM. Gerdes,
HK, PP, SS, NS; Bremen: VB, SH-L, AK, PL, FP, E-MS. Additional support was provided by
the coordinating center for clinical studies in Dresden (KKS Dresden): XG and MK.
The RCT project was approved by the Ethics Committee of the Medical Faculty of
the Technische Universität Dresden (EK 164082006). The neuroimaging components
were approved by the Ethics Committee of the Medical Faculty of the Rheinisch-
Westfaehlische Hochschule University Aachen (EK 073/07) and at all local sites.
The experimental pharmacology study was approved by the Ethics Committee of
the state of Berlin (EudraCT: 2006-00-4860-29). The study was registered with the
ISRCTN: ISRCTN80046034.
REFERENCES
1 Deckert J, Weber H, Villmann C, Lonsdorf TB, Richter J, Andreatta M et al. GLRB
allelic variation predisposes to agoraphobia by increasing startle response. Mol
Psychiatry 2017; doi: 10.1038/mp.2017.2 (e-pub ahead of print).
2 Insel TR, Cuthbert BN, Garvey M, Heinssen R, Pine DS, Quinn K et al. Research
domain criteria (RDoC): toward a new classiﬁcation framework for research on
mental disorders. Am J Psychiatry 2010; 167: 748–751.
3 Stroebe W, Strack F. The Alleged crisis and the illusion of exact replication.
Perspect Psychol Sci 2014; 9: 59–71.
4 Open Science Collaboration. Estimating the reproducibility of psychological
science. Science 2015; 349: aac4716.
5 Fanselow MS. Neural organization of the defensive behavior system responsible
for fear. Psychonom Bull Rev 1994; 1: 429–438.
6 Blanchard DC, Hynd AL, Minke KA, Minemoto T, Blanchard RJ. Human defensive
behaviors to threat scenarios show parallels to fear- and anxiety-related defense
patterns of non-human mammals. Neurosci Biobehav Rev 2001; 25: 761–770.
7 Mobbs D, Hagan CC, Dalgleish T, Silston B, Prevost C. The ecology of human fear:
survival optimization and the nervous system. Front Neurosci 2015; 9: 55.
8 McNaughton N, Corr PJ. A two-dimensional neuropsychology of defense: fear/
anxiety and defensive distance. Neurosci Biobehav Rev 2004; 28: 285–305.
9 Mobbs D, Petrovic P, Marchant JL, Hassabis D, Weiskopf N, Seymour B et al. When
fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts
in humans. Science 2007; 317: 1079–1083.
10 Mobbs D, Marchant JL, Hassabis D, Seymour B, Tan G, Gray M et al. From threat to
fear: The neural organization of defensive fear systems in humans. J Neurosci
2009; 29: 12236–12243.
11 Sehlmeyer C, Schoning S, Zwitserlood P, Pﬂeiderer B, Kircher T, Arolt V et al.
Human fear conditioning and extinction in neuroimaging: A systematic review.
PLoS ONE 2009; 4: e5865.
12 Fullana MA, Harrison BJ, Soriano-Mas C, Vervliet B, Cardoner N, Avila-Parcet A et al.
Neural signatures of human fear conditioning: an updated and extended meta-
analysis of fMRI studies. Mol Psychiatry 2016; 21: 500–508.
13 Fredrikson M, Annas P, Hettema JM. Different genetic factors underlie fear con-
ditioning and episodic memory. Psychiatr Genet 2015; 25: 155–162.
14 Hettema JM, Annas P, Neale MC, Kendler KS, Fredrikson M. A twin study of the
genetics of fear conditioning. Arch Gen Psychiatry 2003; 60: 702–708.
15 Royce JR. Avoidance conditioning in nine strains of inbred mice using optimal
stimulus parameters. Behav Genet 1972; 2: 107–110.
16 Gordon JA, Hen R. Genetic approaches to the study of anxiety. Annu Rev Neurosci
2004; 27: 193–222.
17 Anokhin AP, Golosheykin S, Heath AC. Genetic and environmental inﬂuences on
emotion-modulated startle reﬂex: a twin study. Psychophysiology 2007; 44:
106–112.
18 Hasenkamp W, Epstein MP, Green A, Wilcox L, Boshoven W, Lewison B et al.
Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency
in schizophrenia and control families. Psychiatry Res 2010; 178: 236–243.
19 Blokland GA, de Zubicaray GI, McMahon KL, Wright MJ. Genetic and environ-
mental inﬂuences on neuroimaging phenotypes: a meta-analytical perspective on
twin imaging studies. Twin Res Hum Genet 2012; 15: 351–371.
20 Koten JW Jr, Wood G, Hagoort P, Goebel R, Propping P, Willmes K et al. Genetic
contribution to variation in cognitive function: an FMRI study in twins. Science
2009; 323: 1737–1740.
21 Manuck SB, Brown SM, Forbes EE, Hariri AR.. Temporal stability of individual
differences in amygdala reactivity. Am J Psychiatry 2007; 164: 1613–1614.
22 Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The
Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and
validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
J Clin Psychiatry 1998; 59(Suppl 20): 22–33.
23 Gloster AT, Wittchen HU, Einsle F, Hoﬂer M, Lang T, Helbig-Lang S et al.
Mechanism of action in CBT (MAC): methods of a multi-center randomized con-
trolled trial in 369 patients with panic disorder and agoraphobia. Eur Arch Psy-
chiatry Clin Neurosci 2009; 259(Suppl 2): S155–S166.
24 Lueken U, Straube B, Reinhardt I, Maslowski NI, Wittchen HU, Strohle A et al.
Altered top-down and bottom-up processing of fear conditioning in panic dis-
order with agoraphobia. Psychol Med 2014; 44: 381–394.
25 Wittchen HU, Pﬁster H. DIA-X Interview. Swets & Zeitlinger: Frankfurt, 1997.
26 Haaker J, Lonsdorf TB, Thanellou A, Kalisch R. Multimodal assessment of
long-term memory recall and reinstatement in a combined cue and context
fear conditioning and extinction paradigm in humans. PLoS ONE 2013;
8: e76179.
27 Kuhn M, Haaker J, Glotzbach-Schoon E, Schumann D, Andreatta M, Mechias ML
et al. Converging evidence for an impact of a functional NOS gene variation on
anxiety-related processes. Soc Cogn Affect Neurosci 2016; 11: 803–812.
28 Lonsdorf TB, Haaker J, Kalisch R. Long-term expression of human contextual fear
and extinction memories involves amygdala, hippocampus and ventromedial
prefrontal cortex: a reinstatement study in two independent samples. Soc Cogn
Affect Neurosci 2014; 9: 1973–1983.
29 Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;
38: 95–113.
30 Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N
et al. Automated anatomical labeling of activations in SPM using a macroscopic
anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15:
273–289.
31 Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for
neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.
Neuroimage 2003; 19: 1233–1239.
32 Kircher T, Arolt V, Jansen A, Pyka M, Reinhardt I, Kellermann T et al. Effect of
cognitive behavioural therapy on neural correlates of fear conditioning in panic
disorder. Biol Psychiatry 2013; 73: 93–101.
33 Bradley MM, Lang PJ. Measuring emotion - the self-assessment mannequin and
the semantic differential. J Behav Ther Exp Psychiatr 1994; 25: 49–59.
34 Beck AT, Steer RA, Brown GK. Beck Depression Inventory, 2nd ed. The Psychological
Corporation: San Antonio, 1996.
35 Friedman L, Glover GH, Krenz D, Magnotta V. Reducing inter-scanner variability of
activation in a multicenter fMRI study: role of smoothness equalization. Neuro-
image 2006; 32: 1656–1668.
36 Lueken U, Straube B, Konrad C, Wittchen HU, Strohle A, Wittmann A et al. Neural
substrates of treatment response to cognitive-behavioral therapy in panic dis-
order with agoraphobia. Am J Psychiatry 2013; 170: 1345–1355.
37 Slotnick SD, Moo LR, Segal JB, Hart J Jr. Distinct prefrontal cortex activity asso-
ciated with item memory and source memory for visual shapes. Brain Res Cogn
Brain Res 2003; 17: 75–82.
38 Craig AD. How do you feel–now? The anterior insula and human awareness. Nat
Rev Neurosci 2009; 10: 59–70.
39 Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of
emotional processing in PTSD, social anxiety disorder, and speciﬁc phobia. Am J
Psychiatry 2007; 164: 1476–1488.
40 Chung SK, Bode A, Cushion TD, Thomas RH, Hunt C, Wood SE et al. GLRB
is the third major gene of effect in hyperekplexia. Hum Mol Gen 2013; 22:
927–940.
41 James VM, Bode A, Chung SK, Gill JL, Nielsen M, Cowan FM et al. Novel missense
mutations in the glycine receptor beta subunit gene (GLRB) in startle disease.
Neurobiol Dis 2013; 52: 137–149.
GLRB modulation of defensive reactivity
U Lueken et al
9
Translational Psychiatry (2017), 1 – 10
42 Becker CM. Disorders of the inhibitory glycine receptor: the spastic mouse. FASEB
J 1990; 4: 2767–2774.
43 Schaefer N, Langlhofer G, Kluck CJ, Villmann C. Glycine receptor mouse
mutants: model systems for human hyperekplexia. British J Pharmacol 2013; 170:
933–952.
44 Lynch JW. Molecular structure and function of the glycine receptor chloride
channel. Physiol Rev 2004; 84: 1051–1095.
45 Weltzien F, Puller C, O'Sullivan GA, Paarmann I, Betz H. Distribution of the glycine
receptor beta-subunit in the mouse CNS as revealed by a novel monoclonal
antibody. J Comp Neurol 2012; 520: 3962–3981.
46 Jonsson S, Morud J, Pickering C, Adermark L, Ericson M, Soderpalm B. Changes in
glycine receptor subunit expression in forebrain regions of the Wistar rat over
development. Brain Res 2012; 1446: 12–21.
47 Park S, Tyszka JM, Allman JM. The claustrum and insula in Microcebus murinus: a
high resolution diffusion imaging study. Front Neuroanatomy 2012; 6: 21.
48 Fischer DB, Boes AD, Demertzi A, Evrard HC, Laureys S, Edlow BL et al. A human
brain network derived from coma-causing brainstem lesions. Neurology 2016; 87:
2427–2434.
49 Christianson JP, Fernando ABP, Kazama AM, Jovanovic T, Ostroff LE, Sangha S.
Inhibition of fear by learned safety signals: minisymposium review. J Neurosci
2012; 32: 14118–14124.
50 Duits P, Cath DC, Lissek S, Hox JJ, Hamm AO, Engelhard IM et al. Updated meta-
analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety
2015; 32: 239–253.
51 Lissek S, Rabin SJ, McDowell DJ, Dvir S, Bradford DE, Geraci M et al. Impaired
discriminative fear-conditioning resulting from elevated fear responding to
learned safety cues among individuals with panic disorder. Behav Res Ther 2009;
47: 111–118.
52 Tuescher O, Protopopescu X, Pan H, Cloitre M, Butler T, Goldstein M et al. Dif-
ferential activity of subgenual cingulate and brainstem in panic disorder
and PTSD. J Anxiety Disord 2011; 25: 251–257.
53 Lindner K, Neubert J, Pfannmoller J, Lotze M, Hamm AO, Wendt J. Fear-
potentiated startle processing in humans: Parallel fMRI and orbicularis EMG
assessment during cue conditioning and extinction. Int J Psychophysiol 2015; 98(3
Pt 2): 535–545.
54 Quast C, Altmann A, Weber P, Arloth J, Bader D, Heck A et al. Rare variants in
TMEM132D in a case-control sample for panic disorder. Am J Med Genet 2012;
159b: 896–907.
55 Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S et al. TMEM132D, a
new candidate for anxiety phenotypes: evidence from human and mouse studies.
Mol Psychiatry 2011; 16: 647–663.
56 Haaker J, Lonsdorf TB, Raczka KA, Mechias ML, Gartmann N, Kalisch R. Higher
anxiety and larger amygdala volumes in carriers of a TMEM132D risk variant for
panic disorder. Transl Psychiatry 2014; 4: e357.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative Commons
license, users will need to obtain permission from the license holder to reproduce the
material. To view a copy of this license, visit http://creativecommons.org/licenses/
by/4.0/
© The Author(s) 2017
Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)
GLRB modulation of defensive reactivity
U Lueken et al
10
Translational Psychiatry (2017), 1 – 10
